Latest News about SYNH
Recent news which mentions SYNH
Syneos Health, Inc. (SYNH) Q4 2020 Earnings Call Transcript
February 18, 2021
Tickers
SYNH
From Motley Fool
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
February 18, 2021
From Benzinga
Earnings Scheduled For February 18, 2021
February 18, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
February 14, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
February 12, 2021
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 26, 2021
From Benzinga
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 21, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
January 20, 2021
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 15, 2021
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 14, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
January 13, 2021
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
December 02, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
From Benzinga
Earnings Scheduled For October 29, 2020
October 29, 2020
From Benzinga
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
October 25, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 6, 2020
October 06, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.